Thought Leadership


The 'iPhone moment' for obesity treatment – WHEB
Ben Kluftinger writes about Novo Nordisk, who are producing the so-called 'miracle' weight loss drug taking popular culture by storm.
Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article. Please login or join to view. If your organisation is already a member, please contact us for access.
Feast of opportunities: six future food trends – Capital Group
The global food system is undergoing significant upheaval, Capital Group's investment professionals and ESG analysts explore six key innovations across…
Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article. Please login or join to view. If your organisation is already a member, please contact us for access.